.jpg)
Optimizing Co-Pay Investments to Drive Brand Performance and Patient Retention
.jpg)
The Challenge
Co-pay is one of the largest levers on brand performance, yet it is budgeted and reported as a cost. Leaders can see what was spent, not what each dollar returned.
Key Challenges
- Cost, not investment: Spend is tracked at programme level, with no return view by brand, payer or therapy area.
- Support not targeted: The same help goes to everyone, with no view of who needs it and who doesn’t.
- Spend unlinked to outcomes: Reporting can’t show how spend moves share retention or revenue protected.
- Decisions without a test: Co-pay levels are set without competitive context or “what if” modelling.
Our Solution
Competitive Co-Pay Analytics treats co-pay as an investment portfolio. It unifies claims, programme, enrolment and hub data with competitor pricing and formulary data, so every dollar of spend can be tied to a return.
Priced KPIs:
Each index resolves to a dollar impact, including return per $1 of co-pay spend.
Head-to-head benchmarking:
Brand affordability is compared against competing products and biosimilars, by payer.
Targeted support:
Smart segmentation shows who needs support and who doesn’t, by brand, payer, therapy area and patient segment.
Scenario simulation:
Test a co-pay change before committing the spend.
Action by function:
Every KPI carries Program Ops, Market Access and Commercial actions.
The Outcomes
Support Aimed Where It Pays Back:
Investment is targeted by brand, payer, therapy area and patient segment.
4 Funnel Stages Tied to Spend:
Share retention is measured against co-pay spend, from activation and fills to persistence and revenue protected.
3 Functions, One KPI View:
Program Ops, Market Access and Commercial act from the same priced KPIs, so investment decisions don’t split across teams.
Tested Before Committed:
Scenario simulation models a change, for example a $10 co-pay shift, before money is committed.

.jpg)
.jpg)
.jpg)
.jpg)